Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Japan / NCT05685745
Recruiting Observational

Multisite Inventory of Neonatal-Perinatal Interventions (MINI) Minimum Dataset

NCT05685745 · tracked via the Priya Life Science Japan tracker
Sponsor
The University of Texas Health Science Center, Houston
Phase
Observational
Started
2019-01-01
Last updated
2026-07-06

Condition(s) studied

Infant, Extremely PrematureObstetric Labor, PrematurePremature BirthIntensive Care, NeonatalIntensive Care Units, Neonatal

Study summary

The goal of the Tiny Baby Collaborative Multicenter Inventory of Neonatal-Perinatal Interventions (MINI) minimum dataset is to serve as a registry detailing the outcomes and practices for all deliveries and infants admitted to intensive care at 22-23 weeks' gestation at participating hospitals.

Eligibility

Sex
ALL
Min age
0 Years
Max age
1 Year
Healthy volunteers
No
Inclusion Criteria: * All local births with gestational ages of 22 weeks 0 days - 23 weeks 6 days, regardless of pregnancy outcome or neonatal intensive care (NICU) admission; AND * All outborn NICU admissions with gestational age at birth of 22 weeks 0 days - 23 weeks 6 days * Optional: Centers who desire to include data for NICU admissions of infants born \<22 weeks' gestation may also submit these data.

Primary outcome measure(s)

  • Registry of characteristics and outcome data for all deliveries and infants admitted to intensive care at 22-23 weeks' gestation at participating hospitals collected in a uniform manner — Longitudinal database through 1/2028

Trial sites (59)

FacilityCityRegionStatus
University of Alabama at Birmingham Birmingham Alabama Recruiting
University of South Alabama Mobile Alabama Recruiting
Vallywise Health Medical Center Phoenix Arizona Recruiting
Loma Linda University Children's Hospital Loma Linda California Recruiting
Miller Children's & Women's Hospital Long Beach California Recruiting
Children's Hospital, Orange County Orange California Recruiting
University of California, San Diego San Diego California Recruiting
Joe DiMaggio Children's Hospital Hollywood Florida Recruiting
Wolfson Children's Hospital Jacksonville Florida Recruiting
University of Florida, Jacksonville Jacksonville Florida Recruiting
Orlando Health Winnie Palmer Hospital for Women & Babies Orlando Florida Recruiting
Johns Hopkins All Children's Hospital St. Petersburg Florida Recruiting
Emory University Hospital Midtown Atlanta Georgia Recruiting
Emory University Grady Memorial Atlanta Georgia Recruiting
Memorial Health University Medical Center Savannah Georgia Recruiting
University of Iowa Iowa City Iowa Recruiting
Golisano Children's at the University of Kentucky Lexington Kentucky Recruiting
Massachusetts General Hospital Boston Massachusetts Recruiting
Brigham and Women's Hospital Boston Massachusetts Recruiting
Beth Israel Deaconess Medical Center Boston Massachusetts Recruiting
Nebraska Medicine Omaha Nebraska Recruiting
Hackensack University Medical Center Hackensack New Jersey Recruiting
Golisano Children's Hospital of Buffalo Buffalo New York Recruiting
The Children's Hospital at Montefiore The Bronx New York Recruiting
Duke University Durham North Carolina Recruiting
East Carolina University Greenville North Carolina Recruiting
Cincinnati Children's Hospital Medical Center Cincinnati Ohio Recruiting
Nationwide Children's Hospital Columbus Ohio Recruiting
Oregon Health and Science University Portland Oregon Recruiting
Hospital of the University of Pennsylvania Philadelphia Pennsylvania Recruiting
Pennsylvania Hospital Philadelphia Pennsylvania Recruiting
Texas Health Resources Harris Hospital Fort Worth Texas Recruiting
Texas Children's Hospital Houston Texas Recruiting
The University of Texas Health Science Center at Houston Houston Texas Recruiting
The Women's Hospital of Texas Houston Texas Recruiting
CHRISTUS Children's Hospital San Antonio Texas Recruiting
Methodist Children's Hospital San Antonio Texas Recruiting
St. Luke's Baptist Hospital San Antonio Texas Recruiting
North Central Baptist Hospital San Antonio Texas Recruiting
University of Vermont Burlington Vermont Recruiting

+ 19 more sites — see the full list on the official registry below.

More The University of Texas Health Science Center, Houston trials in Japan

The GUARDIAN Trial - Induction Agent Sub-Study Enrolling by invitation
The GUARDIAN Trial Recruiting
The GUARDIAN Trial - Vasopressor Sub-Study Enrolling by invitation
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05685745 on ClinicalTrials.gov ↗ ← All trials in Japan